Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior TherapyRobert C. Kane, Richard Pazdur, Peter Bross et al.|The Oncologist|2003Cited by 629
Sorafenib for the Treatment of Advanced Renal Cell CarcinomaRobert C. Kane, Richard Pazdur, Haleh Saber et al.|Clinical Cancer Research|2006Cited by 466
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR. Angelo de Claro, Richard Pazdur, Karen M. McGinn et al.|Clinical Cancer Research|2015Cited by 165